Aldeyra Therapeutics, Inc.ALDX
Market cap
$300.08M
P/E ratio
| Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
| Research and development | 4 | 8 | 13 | 16 | 30 | 44 | 25 | 45 | 47 | 29 | 48 |
| General and administrative | 4 | 4 | 6 | 6 | 10 | 12 | 10 | 11 | 15 | 13 | 12 |
| Loss from operations | -7,270,590 | -11,989,107 | -18,695,978 | -22,488,388 | -39,699,151 | -63,074,307 | -36,421,020 | -56,219,536 | -62,679,987 | -42,794,083 | -60,117,032 |
| Interest income | 3 | 11,126 | 102,037 | 261,252 | 952,698 | 2 | 292,224 | 185,363 | 2 | 7 | 6 |
| Interest expense | - | - | - | - | - | - | - | - | - | - | 2 |
| Total other income, net | 2 | -101,180 | -3,472 | 147,799 | 805,906 | 937,503 | -1,611,974 | -1,556,738 | 655,351 | 5 | 4 |
| Net loss | -5,187,259 | -12,090,287 | -18,699,450 | -22,340,589 | -38,893,245 | -60,826,831 | -37,553,729 | -57,776,274 | -62 | -37 | -55,851,444 |
| Earnings Per Share, Basic | -2.51 | -1.4 | - | - | - | - | - | - | -1.06 | -0.64 | -0.94 |
| Earnings Per Share, Diluted | -3.09 | -1.4 | - | - | - | - | - | - | -1.06 | -0.64 | -0.94 |